• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同培养基中生长的脑膜炎奈瑟菌 B 群荚膜多糖疫苗 44/76 株的特征。

Characterization of meningococcal serogroup B outer membrane vesicle vaccines from strain 44/76 after growth in different media.

机构信息

National Institute for Biological Standards and Control, Health Protection Agency, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK.

出版信息

Vaccine. 2010 Apr 19;28(18):3211-8. doi: 10.1016/j.vaccine.2010.02.023. Epub 2010 Feb 25.

DOI:10.1016/j.vaccine.2010.02.023
PMID:20188677
Abstract

In this study, we evaluated the effect of the growth medium on the composition and immunogenicity of meningococcal outer membrane vesicle (OMV) vaccines after cultivation of the Norwegian serogroup B 44/76 vaccine strain in either Frantz' or modified Catlin-6 media (MC.6M). Differential proteomic analysis revealed that 97% of the OMV proteins maintained the same levels in the two preparations. However, a number of differentially expressed proteins, including TdfH, OpcA, OMP NMB0088, hypothetical NMB2134, lipoprotein NMB1126/1164 and NspA, increased significantly in OMVs produced from bacteria grown in the MC.6M. Together with increased lipopolysaccharide levels, the increased expression of these proteins was associated with significantly higher serum bactericidal titres in mice immunized with the MC.6M OMV vaccine. The high resolution two-dimensional separation of the OMVs on a large-format gel across a pH range of 3-11 resolved around 2000 protein spots from which 75 proteins were identified by mass spectrometry.

摘要

在这项研究中,我们评估了生长培养基对脑膜炎球菌外膜囊泡(OMV)疫苗组成和免疫原性的影响,方法是在 Frantz'或改良 Catlin-6 培养基(MC.6M)中培养挪威 B 群 44/76 疫苗株。差异蛋白质组学分析显示,两种制剂中 97%的 OMV 蛋白保持相同水平。然而,一些差异表达的蛋白质,包括 TdfH、OpcA、OMP NMB0088、假设的 NMB2134、脂蛋白 NMB1126/1164 和 NspA,在 MC.6M 中生长的细菌产生的 OMV 中显著增加。与脂多糖水平增加一起,这些蛋白质的高表达与用 MC.6M OMV 疫苗免疫的小鼠中的血清杀菌滴度显著增加有关。在 pH 范围为 3-11 的大格式凝胶上对 OMV 进行高分辨率二维分离,可从其中分离出约 2000 个蛋白质斑点,通过质谱鉴定出 75 种蛋白质。

相似文献

1
Characterization of meningococcal serogroup B outer membrane vesicle vaccines from strain 44/76 after growth in different media.不同培养基中生长的脑膜炎奈瑟菌 B 群荚膜多糖疫苗 44/76 株的特征。
Vaccine. 2010 Apr 19;28(18):3211-8. doi: 10.1016/j.vaccine.2010.02.023. Epub 2010 Feb 25.
2
Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254.对由B群菌株NZ98/254制备的脑膜炎球菌外膜囊泡疫苗进行蛋白质组学分析。
Proteomics. 2006 Jun;6(11):3400-13. doi: 10.1002/pmic.200500821.
3
Outer membrane vesicles of the VA-MENGOC-BC vaccine against serogroup B of Neisseria meningitidis: Analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry.针对B群脑膜炎奈瑟菌的VA-MENGOC-BC疫苗的外膜囊泡:通过二维凝胶电泳和质谱分析蛋白质成分
Proteomics. 2006 Jun;6(11):3389-99. doi: 10.1002/pmic.200500502.
4
Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.抗A群脑膜炎奈瑟菌外膜囊泡疫苗的研发与特性分析
Vaccine. 2005 May 31;23(29):3762-74. doi: 10.1016/j.vaccine.2005.02.021. Epub 2005 Mar 14.
5
Proteomic analysis of Neisseria lactamica and N eisseria meningitidis outer membrane vesicle vaccine antigens.乳酸奈瑟菌和脑膜炎奈瑟菌外膜囊泡疫苗抗原的蛋白质组学分析
Vaccine. 2006 Jun 19;24(25):5277-93. doi: 10.1016/j.vaccine.2006.03.013. Epub 2006 Mar 23.
6
Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate.来自B群脑膜炎奈瑟菌的脂蛋白NMB0928作为一种新型疫苗候选物。
Vaccine. 2007 Dec 5;25(50):8420-31. doi: 10.1016/j.vaccine.2007.09.053. Epub 2007 Oct 11.
7
Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.含有脑膜炎奈瑟菌外膜囊泡的疫苗的特性及临床性能
Vaccine. 2009 Jun 24;27 Suppl 2:B3-12. doi: 10.1016/j.vaccine.2009.04.071. Epub 2009 May 28.
8
Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines.脑膜炎奈瑟菌外膜囊泡的佐剂特性及佐剂在脑膜炎奈瑟菌蛋白疫苗中的应用。
Expert Rev Vaccines. 2011 Mar;10(3):323-34. doi: 10.1586/erv.11.10.
9
Challenges and progress in the development of a serogroup B meningococcal vaccine.B 群脑膜炎球菌疫苗研发中的挑战与进展
Expert Rev Vaccines. 2009 Jun;8(6):729-45. doi: 10.1586/erv.09.30.
10
Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process.采用基因工程菌株和无洗涤剂纯化工艺改良的脑膜炎奈瑟菌 OMV 疫苗。
Vaccine. 2010 Jul 5;28(30):4810-6. doi: 10.1016/j.vaccine.2010.04.082. Epub 2010 May 16.

引用本文的文献

1
Consistency in bacterial extracellular vesicle production: key to their application in human health.细菌细胞外囊泡生产的一致性:其在人类健康中应用的关键。
Extracell Vesicles Circ Nucl Acids. 2025 Jan 17;6(1):1-20. doi: 10.20517/evcna.2024.76. eCollection 2025.
2
Streptococcus mutans membrane vesicles inhibit the biofilm formation of Streptococcus gordonii and Streptococcus sanguinis.变形链球菌膜泡抑制戈登链球菌和血链球菌的生物膜形成。
AMB Express. 2022 Dec 12;12(1):154. doi: 10.1186/s13568-022-01499-3.
3
Isolation Method and Characterization of Outer Membranes Vesicles of Grown in a Chemically Defined Medium.
在化学限定培养基中生长的[具体生物名称未给出]外膜囊泡的分离方法及特性研究
Front Microbiol. 2021 Jun 2;12:654193. doi: 10.3389/fmicb.2021.654193. eCollection 2021.
4
Extracellular Vesicle Analysis by Paper Spray Ionization Mass Spectrometry.通过纸喷雾电离质谱法进行细胞外囊泡分析
Metabolites. 2021 May 11;11(5):308. doi: 10.3390/metabo11050308.
5
Hydrostatic Filtration Enables Large-Scale Production of Outer Membrane Vesicles That Effectively Protect Chickens against .静水压过滤可实现外膜囊泡的大规模生产,这些外膜囊泡能有效保护鸡免受……
Vaccines (Basel). 2020 Jan 23;8(1):40. doi: 10.3390/vaccines8010040.
6
Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.淋病奈瑟菌同源物与 B 群脑膜炎奈瑟球菌外膜蛋白的遗传相似性。
mBio. 2019 Sep 10;10(5):e01668-19. doi: 10.1128/mBio.01668-19.
7
A homopolymeric adenosine tract in the promoter region of nspA influences factor H-mediated serum resistance in Neisseria meningitidis.启动子区域内的一段富含腺嘌呤的核苷酸序列影响脑膜炎奈瑟菌中因子 H 介导的血清抗性。
Sci Rep. 2019 Feb 25;9(1):2736. doi: 10.1038/s41598-019-39231-0.
8
A deeper mining on the protein composition of VA-MENGOC-BC®: An OMV-based vaccine against N. meningitidis serogroup B and C.更深入地挖掘 VA-MENGOC-BC® 疫苗的蛋白组成:一种针对 B 群和 C 群脑膜炎奈瑟菌的 OMV 疫苗。
Hum Vaccin Immunother. 2017 Nov 2;13(11):2548-2560. doi: 10.1080/21645515.2017.1356961. Epub 2017 Oct 30.
9
Outer membrane vesicles as platform vaccine technology.外膜囊泡作为平台疫苗技术
Biotechnol J. 2015 Sep;10(11):1689-706. doi: 10.1002/biot.201400395.
10
An OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and Toxicity.一种源自具有组成型FetA表达的B群脑膜炎球菌的外膜囊泡疫苗:免疫原性和毒性的临床前评估
PLoS One. 2015 Sep 21;10(9):e0134353. doi: 10.1371/journal.pone.0134353. eCollection 2015.